Hepion Pharmaceuticals, Inc. — SC 13G Filings
18 SC 13G filings on record
This page lists all SC 13G filings submitted to the SEC by Hepion Pharmaceuticals, Inc. (CTRVP), sorted by most recent first. Each row links to the full filing on EdgarLookup. Hepion Pharmaceuticals, Inc. has filed 18 SC 13G documents with the SEC since 2013. To view all SEC filings by Hepion Pharmaceuticals, Inc., see the full filings list.
All
10-12G
10-12G/A
10-K
10-K/A
10-KT
10-Q
10-Q/A
25-NSE
3
4
424B3
424B4
424B5
425
8-A12B
8-K
8-K/A
ARS
ARS/A
CERTNAS
CORRESP
CT ORDER
D
DEF 14A
DEFA14A
EFFECT
FWP
NT 10-K
NT 10-Q
PRE 14A
PRER14A
RW
RW WD
S-1
S-1/A
S-1MEF
S-3
S-3/A
S-8
SC 13D
SC 13D/A
SC 13G
SC 13G/A
SCHEDULE 13G
SCHEDULE 13G/A
UPLOAD
| Form | Description | Accession Number | Filed | Period |
|---|---|---|---|---|
| SC 13G | — | 0001172661-24-001361 | Feb 14, 2024 | — |
| SC 13G | ACQUISITION OF BENEFICIAL OWNERSHIP | 0001387131-21-002768 | Feb 24, 2021 | — |
| SC 13G | SABBY 13G HEPA 2.19.21 | 0001535610-21-000079 | Feb 19, 2021 | — |
| SC 13G | HEPION PHARMACEUTICALS, INC. | 0000902664-21-001479 | Feb 18, 2021 | — |
| SC 13G | SCHEDULE 13G | 0001104659-21-018267 | Feb 10, 2021 | — |
| SC 13G | SCHEDULE 13G | 0001387131-20-010634 | Dec 9, 2020 | — |
| SC 13G | HEPION PHARMACEUTICALS, INC. | 0000902664-20-004112 | Dec 2, 2020 | — |
| SC 13G | SABBY 13G HEPA 12.01.20 | 0001535610-20-000122 | Dec 2, 2020 | — |
| SC 13G | HEPA 13G | 0001393825-20-000049 | Feb 5, 2020 | — |
| SC 13G | SC 13G | 0001193125-19-185110 | Jun 28, 2019 | — |
| SC 13G | SC 13G | 0001104659-19-037772 | Jun 27, 2019 | — |
| SC 13G | SC 13G | 0001104659-19-019188 | Apr 2, 2019 | — |
| SC 13G | NONE | 0001567619-19-007023 | Mar 18, 2019 | — |
| SC 13G | — | 0001770632-19-000002 | Mar 15, 2019 | — |
| SC 13G | SC 13G | 0001193125-18-224755 | Jul 24, 2018 | — |
| SC 13G | SC 13G | 0001104659-16-140283 | Aug 17, 2016 | — |
| SC 13G | SC 13G | 0001104659-15-070808 | Oct 15, 2015 | — |
| SC 13G | EMPERY ASSET MANAGEMENT, LP | 0000902664-15-003912 | Oct 14, 2015 | — |